Please assess the completion status of the following clinical trial:

Trial Title: An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female subjects of non-childbearing potential and male subjects between the ages of 40 and 80 years, inclusive~* Subjects with a diagnosis, for at least 6 months, of moderate to severe COPD and who meet the criteria for Stage II-III disease~* Subjects must have a smoking history of at least 10 pack-years~Exclusion Criteria:~* Current evidence or history within the previous 6 months of any clinically significant disease (other than COPD) or abnormality in the opinion of the Investigator that would put the subject at risk or which would compromise the quality of the study data~* A COPD exacerbation requiring treatment with oral steroids or hospitalization for the treatment of COPD within 3 months of Screening

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Double blind placebo for PF-03715455
- PF-03715455 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).